HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of laparoscopic duodenal switch for morbid obesity.

AbstractBACKGROUND:
The aim of this study was to determine the safety and efficacy of laparoscopic duodenal switch (LDS) as a treatment option in a selected group of patients with morbid obesity.
METHODS:
This retrospective analysis of a prospective database assessed the frequency of all complications and alterations in weight, body mass index (BMI), co-morbidity and quality of life.
RESULTS:
One hundred and twenty-one patients underwent LDS between April 2003 and March 2009. Median preoperative weight was 160 kg and median BMI 55 kg/m(2). All procedures were performed laparoscopically. The in-hospital mortality rate was zero. No ileoduodenal anastomotic stenosis was encountered. There were four clinical leaks (3·3 per cent) managed by laparoscopic drainage and placement of a feeding jejunostomy. Median percentage excess weight loss was 75 per cent at 12 months and 90 per cent at 24 months. Thirty-six of 40 diabetic patients had complete resolution of diabetes within 1 year. There were significant improvements in other obesity-related co-morbidity. Only a few patients developed postoperative protein deficiency, and fat-soluble vitamin deficiencies were easily managed with oral supplementation.
CONCLUSION:
The LDS procedure is a safe and effective treatment for morbid obesity and its associated co-morbidity in selected patients.
AuthorsC J Magee, J Barry, J Brocklehurst, S Javed, R Macadam, D D Kerrigan
JournalThe British journal of surgery (Br J Surg) Vol. 98 Issue 1 Pg. 79-84 (Jan 2011) ISSN: 1365-2168 [Electronic] England
PMID20967827 (Publication Type: Journal Article)
CopyrightCopyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Topics
  • Adult
  • Anastomosis, Surgical
  • Body Mass Index
  • Duodenum (surgery)
  • Female
  • Gastrectomy (methods)
  • Hospital Mortality
  • Humans
  • Ileostomy (methods)
  • Laparoscopy (adverse effects, methods)
  • Longevity
  • Male
  • Middle Aged
  • Obesity, Morbid (mortality, surgery)
  • Postoperative Care
  • Postoperative Complications (etiology)
  • Quality of Life
  • Retrospective Studies
  • Treatment Outcome
  • Weight Loss

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: